As a successful result of such a mobilization, an arsenal of ALK tyrosine kinase inhibitors (ALK TKIs) is now available [3,7,8,9], and their use has been proven to be beneficial in many ALK-associated cancer patients [10,11,12]. Here, ALK is linked to cancer.